Press "Enter" to skip to content

New patent for Sanofi-aventis Us drug ADMELOG

0
Listen to this article
Copyright © DrugPatentWatch. Originally published at New patent for Sanofi-aventis Us drug ADMELOG

Annual Drug Patent Expirations for ADMELOG
Annual Drug Patent Expirations for ADMELOG

Admelog is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

Admelog drug price trends.

The generic ingredient in ADMELOG is insulin lispro. One supplier is listed for this compound. Additional details are available on the insulin lispro profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Sanofi-aventis Us drug ADMELOG
Do NOT follow this link or you will be banned from the site!